Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 116
Selected: 0
NCT IDTitle
NCT01802749Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
NCT01651013Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras
NCT01651026Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer
NCT06341764Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma
NCT00657878Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
NCT06866093The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical.
NCT04071704Assessing Health-related Quality of Life in Sarcoma Patients
NCT04854213PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)
NCT04129255Octreotide LAR in the Induction of Immunologic Response in NENs Patients
NCT07175350Financial Toxicity (FT) for Radiotherapy (RT) Patients in Italy: a yAIRO (Associazione Italiana Radioterapia e Ocologia Clinica) Multicenter Study
NCT06218511A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)
NCT05818020Multidisciplinary Integrated Platform for a Technological Innvovative Approach to Oncotherapies
NCT07027046Application of da Vinci SP for Endometrial Cancer Surgical Staging
NCT04129281Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma
NCT03891485Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy
NCT03473379Development and Validation of a Tool for Patient-reported Assessment of Cancer-related Financial Toxicity in Italy
NCT02624128Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
NCT05733806Study on Gynecological Rare Cancers
NCT01755182Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors
NCT06880523STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
NCT04290299Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive
NCT00660842Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer
NCT02273375Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
NCT05817227Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
NCT01801904A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer
NCT06905145Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
NCT04595032MAnagement of METastatic Disease in Campania (MAMETIC)
NCT00401427HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer
NCT00401635END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin
NCT07213557Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy
NCT02786875Diet, Exercise and Vitamin D in Breast Cancer Recurrence
NCT01656551MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer
NCT01481545Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer
NCT06886282Spatial RadiomIcs and TRanscriptomics to the DIscovery of the Cross-link Between Colon Cancer and ChrOnic Kidney Disease
NCT01706120Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab
NCT04139772Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.
NCT02381054Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients
NCT00401674MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer
NCT02784171Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
NCT00415779ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer
NCT07302451REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)
NCT01005641ELBA: Exemestane and Lapatinib in Advanced Breast Cancer
NCT02618850PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment
NCT04416672Validation of the Italian Version of the PRO-CTCAE
NCT01359956Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma
NCT06032975PRO for Fighting FT in Ovarian Cancer
NCT04122911Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas
NCT01898104Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer
NCT03203005IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients
NCT03975114A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5)